Concepedia

Penney Khamphavong

PK

Statistics

Publications

3

Citations

241

H-Index

3

Active since

2011

Affiliations

Pfizer (United States)(Current)

Penney Khamphavong is an author at Pfizer (United States) specializing in pharmacy, pharmacology, and ocular targeted delivery.

Publications per year

2011–2022

3

Publications

3

Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (<i>R</i>)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (PF-06821497)

Pei‐Pei Kung, Patrick Bingham, Alexei Brooun et al. · Journal of Medicinal Chemistry · 2017 · 128 citations · Full text

, , +17

Reversible lysine-targeted probes reveal residence time-based kinase selectivity

Tangpo Yang, Adolfo Cuesta, Xiaobo Wan et al. · Nature Chemical Biology · 2022 · 103 citations · Full text

, , +8

Solution Formulation Development of a VEGF Inhibitor for Intravitreal Injection

Michelle T. Marra, Penney Khamphavong, Peter Wisniecki et al. · AAPS PharmSciTech · 2011 · 10 citations · Full text

, , +16

1–3 of 3